1. Interval prolongation of etanercept in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a randomized controlled trial. (4th March 2023) Authors: Ruwaard, J; L' Ami, MJ; Kneepkens, EL; Krieckaert, CLM; Nurmohamed, MT; Hooijberg, F; van Kuijk, AWR; van Denderen, JC; Burgemeister, L; Rispens, T; Boers, M; Wolbink, GJ Journal: Scandinavian journal of rheumatology Issue: Volume 52:Number 2(2023) Page Start: 129 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗